This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Healthcare ETFs Head to Head: XLV vs. VHT
by Zacks Equity Research
Head to head comparison of two Healthcare ETFs, XLV and VHT.
Healthcare ETFs in Focus on Johnson & Johnson Q3 Earnings
by Zacks Equity Research
Johnson & Johnson reports Q3 results with both revenues and EPS beating estimates.
Ride On UnitedHealth Q3 Strength with These ETFs
by Sanghamitra Saha
Play upbeat earnings of UnitedHealth Group with these ETFs.
ETFs to Buy After Weak Jobs Report
by Sanghamitra Saha
Hurricanes hit U.S. September job data hard. But these ETFs still hold promise.
4 Big ETF Launches of Third-Quarter 2017
by Sweta Killa
We highlight four ETFs that have been able to pull in over $120 million in AUM and have huge potential to dominate the market in the coming months.
Stock Investing Strategy When at All Time Highs
by Jeremy Mullin
If you want to participate in the next round of new highs, then NOW is the time to develop a game plan. Jeremy Mullin will show you how.
Volatility Spikes on Geopolitics: 4 ETF Tactics to Shield
by Sweta Killa
We have highlighted certain ETF techniques that could lead to a winning portfolio amid the heightened geopolitical tension.
J&J Brightens Outlook: Healthcare ETFs in Focus
by Sweta Killa
Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.
How to Build a Winning ETF Portfolio for Second-Half 2017
by Sweta Killa
If we go by history, stocks have generated positive returns in the second half of the year over the past two decades.
Top Ranked Healthcare ETFs for Long Term Investors
by Neena Mishra
Healthcare was the best performing sector in Q2; we discuss the reasons behind the outperformance and the best ETFs for investors.